dcsimg

About Prolia® (denosumab)

inner_banner
  •  Home
  • >
  • About Prolia® (denosumab)

About Prolia® (denosumab)

Prolia® (denosumab) is used to treat:
  • Osteoporosis in women after the menopause (postmenopausal) and men who have an increased risk of fracture (broken bones), reducing the risk of spinal, non-spinal and hip fractures.
  • Bone loss that results from a reduction in hormone (testosterone) level caused by surgery or treatment with medicines in patients with prostate cancer.
Throughout life your bones are constantly changing while your body removes old bone and replaces it with new bone. After the menopause bone loss becomes more rapid and bones can become thin and fragile. Bone loss can also occur in men due to ageing or a low level of the hormone testosterone.
Prolia® mimics a protein found in your body that blocks the process causing bone loss. By blocking the process of bone loss Prolia® makes bone stronger and less likely to break, especially in the spine and hips.1
The treatment effect of Prolia® does wear off if treatment is stopped, so it is important you continue to get your injection every six months.
References
  1. Prolia® (denosumab) Patient Information Leaflet